US Patent 9527900 Double-acylated GLP-1 derivatives
Patent 9527900 was granted and assigned to Novo Nordisk on December, 2016 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
December 7, 2015
Date of Patent
December 27, 2016
Patent Applicant
Patent Application Number
14961064
Patent Citations Received
Patent Inventor Names
Lars Linderoth
0
Jacob Kofoed
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9527900 Double-acylated GLP-1 derivatives
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
